These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28086239)

  • 21. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.
    Ji L; Ni T; Shen Y; Xue Q; Liu Y; Chen B; Cui X; Lv L; Yu X; Cui Y; Lu X; Chen J; Mao G; Wang Y
    J Mol Histol; 2014 Oct; 45(5):573-82. PubMed ID: 24952301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of annexin II expression in human non-small cell lung cancer.
    Jia JW; Li KL; Wu JX; Guo SL
    Tumour Biol; 2013 Jun; 34(3):1767-71. PubMed ID: 23494179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
    Zhu B; Yan Y; Shao B; Tian L; Zhou W
    J Int Med Res; 2018 Apr; 46(4):1517-1527. PubMed ID: 29363378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
    Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
    Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
    Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
    J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.
    Zhao L; Jiang L; Wang L; He J; Yu H; Sun G; Chen J; Xiu Q; Li B
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1951-61. PubMed ID: 22760214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
    Gharabaghi MA
    Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population.
    Liu SG; Yuan SH; Wu HY; Huang CS; Liu J
    Tumour Biol; 2014 Sep; 35(9):8679-83. PubMed ID: 24870593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
    Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
    BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
    J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and clinical significance of IL-33 in patients with non-small cell lung cancer].
    Feng Y; Zhu Y; Luo G; Wang Z; Yu P; Zheng L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):808-11. PubMed ID: 27371849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.